This suggests that the Akirin2‐PTEN signaling pathway may, at least in part, be a potential mechanism underlying the neuroprotective effect of tDCS and ISO in cerebral ischemia/reperfusion injury. The gene discussed is PTEN; the disease is brain ischemia.